Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting

v3.3.0.814
Segment Reporting
 3 Months Ended
Sep. 30, 2015
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
13. Segment Reporting
 
As discussed above, iBio Brazil began operations in the first quarter of fiscal 2015. In accordance with FASB ASC 280, “Segment Reporting,” the Company discloses financial and descriptive information about its reportable geographic segments. Geographic segments are components of an enterprise about which separate financial information is available and regularly evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance.
 
 
 
 
 
iBio
 
 
 
Three months ended September 30, 2015
 
iBio
 
Brazil
 
Total
 
 
 
 
 
 
 
 
 
Net revenues
 
$
160
 
$
-
 
$
160
 
Research and development expenses
 
 
551
 
 
-
 
 
551
 
General and administrative expenses
 
 
1,416
 
 
6
 
 
1,422
 
Operating loss
 
 
(1,807)
 
 
(6)
 
 
(1,813)
 
 
 
 
 
 
iBio
 
 
 
Three months ended September 30, 2014
 
iBio
 
Brazil
 
Total
 
 
 
 
 
 
 
 
 
Net revenues
 
$
819
 
$
-
 
$
819
 
Research and development expenses
 
 
1,185
 
 
-
 
 
1,185
 
General and administrative expenses
 
 
1,029
 
 
21
 
 
1,050
 
Operating loss
 
 
(1,395)
 
 
(21)
 
 
(1,416)
 
 
 
 
 
 
iBio
 
 
 
Total Assets for the Business Segments
 
iBio
 
Brazil
 
Total
 
 
 
 
 
 
 
 
 
September 30, 2015 (unaudited)
 
$
11,344
 
$
30
 
$
11,374
 
June 30, 2015
 
 
12,448
 
 
46
 
 
12,494